DHR Danaher Corporation Common Stock
O Danaher Corporation Common Stock Przegląd firmy z Wikipedii
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
Czytaj więcej
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.
History
Early years
The company's origins go back to DMG, Inc., a Massachusetts real estate investment trust organized in 1969. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. In 1983, the Stephen M. Rales and Mitchell P. Rales invested in the company, which at that time was invested in retirement home developments, they then replaced the existing management in a bitter proxy battle. The name came from a river in Montana.
In 1984, the company adopted the name Danaher and reincorporated under the Delaware General Corporation Law.
In 1985, the Rales brothers offered $400 million in a hostile bid for Scott Fetzer Company but lost out to Berkshire Hathaway.
In June 1986, Danaher acquired Chicago Pneumatic in a hostile takeover, offering $60.8 million for the 32% of the company not already owned. The company had merged in July 1984 with a sister company, the Jacobs Manufacturing Co., and had purchased Matco Tools in April 1981.
In June 1987, Danaher sold Chicago Pneumatic while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.
In 1986, Danaher added Qualitrol to its instrumentation unit, including Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors, and pressure measurement and temperature measurement instruments used on the electrical transformer industry.
1990–2000
In 1990, Danaher acquired Easco Hand Tools Inc. Danaher was selected as exclusive supplier of hand tools for Sears. In 1994, Danaher acquired Armstrong Tools, the makers of tool brands Armstrong, Allen, and others.
In 1995, Danaher acquired Hengstler GmbH, a manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition headquartered outside the United States.
In 1999, the company acquired Hach Company, involved in water and wastewater—and analytics, for $325 million.
2001–2010
In 2000, H. Lawrence Culp Jr. was named CEO of Danaher; he had joined the company in 1990.
Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.
Danaher also acquired UK-based West Instruments, which provides control and measurement instrumentation and services for the global industrial and process markets.
Danaher announced its agreement to acquire the Gendex division from DENTSPLY International on
December 11, 2003, with the acquisition closing in early 2004, integrating this dental imaging company into Danaher's growing dental portfolio.
PMA, a German manufacturer of control and measurement instrumentation, was acquired in April 2005.
In July 2005, Danaher acquired Leica Microsystems, which manufactures products for applications requiring microscopic imaging, measurement and analysis and offers management systems for biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.
In early 2007, Danaher acquired Vision Systems, which manufactures and markets automated instruments, antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases, for $520 million.
In July 2007, Danaher acquired ChemTreat.
In November 2007, Danaher purchased Tektronix for US$2.85 billion.
In 2009, Danaher acquired the Analytical Technologies business unit of MDS, including a 50% interest in AB SCIEX, for US$650 million. In February 2010, Danaher acquired the remaining 50% ownership position in AB SCIEX from Life Technologies for US$450 million.
2011–2020
In 2011, Danaher acquired Beckman Coulter, which was divided into a diagnostics segment and a life sciences segment.
In January 2012, Danaher sold Accu-sort to Datalogic.
In December 2012, Danaher acquired Navman Wireless, a provider of on-demand fleet and asset management technology.
In February 2013, Danaher and Cooper Industries sold their joint venture, Apex Tool Group, to Bain Capital for $1.6 billion.
In September 2014, Danaher acquired Nobel Biocare for $2.2 billion.
Effective March 1, 2015, H. Lawrence Culp Jr. resigned as CEO of Danaher.
In July 2015, Danaher combined its communications unit with NetScout Systems.
In August 2015, Danaher acquired Pall Corporation for $13.8 billion.
In June 2016, Danaher completed the corporate spin-off of Fortive, which included Matco and AMMCO-COATS. In September of the same year, the company announced it would acquire Cepheid for $4 billion including debt.
In October 2016, Danaher acquired Phenomenex for $700 million to expand in life sciences.
In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS). IDBS became part of Danaher's Life Sciences platform.
In March 2018, Danaher acquired Integrated DNA Technologies for an estimated $1.9 billion.
In July 2018, Danaher announced its intention to spin off its Dental segment into a public company, later named Envista Holdings Corporation. The corporate spin-off was completed in December 2019.
In March 2020, Integrated DNA Technologies, a subsidiary of the company, manufactured components for COVID-19 testing.
In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.
Effective September 2020, Tom Joyce retired as CEO of the company; he was replaced by Executive Vice President Rainer Blair.
2021–present
In June 2021, Precision Nanosystems was acquired by Cytiva.
In August 2021, Danaher acquired Aldevron, which produces mRNA and proteins used in mRNA vaccines, for $9.6 billion in cash.
In May 2023, Pall Corporation merged with Cytiva to create a new Biotechnology Group within Danaher; at that time Cytiva employed more than 16,000 associates in over 40 countries.
Also in September 2022, Danaher announced its intention to spin off its Environmental & Applied Solutions segment; in February 2023, it was named Veralto and the corporate spin-off was completed in September 2023. The division included Aquatic Informatics, ChemTreat, Esko, Hach Company, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, and X-Rite.
In December 2023, Danaher acquired Abcam for approximately $5.7 billion.
In June 2024, the Food and Drug Administration granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. Using a blood sample from a fingertip, the rapid test detects the virus's RNA and delivers results in less than roughly an hour, as opposed to requiring a sample to be sent to a lab.
In August 2024, the company acquired GeneData. In February 2026, Danaher announced it would acquire Masimo for $10 billion.
Divisions
Life sciences
Abcam
Beckman Coulter - Life Sciences
Cytiva
Integrated DNA Technologies
Leica Microsystems
Molecular Devices
Pall Corporation
SCIEX
Diagnostics
Beckman Coulter - Diagnostics
Cepheid
Leica Biosystems
Radiometer
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
DHR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
DHR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 26 czerwca 2026 | $0,4000 |
| 27 marca 2026 | $0,4000 |
| 26 grudnia 2025 | $0,3200 |
| 26 września 2025 | $0,3200 |
| 27 czerwca 2025 | $0,3200 |
| 28 marca 2025 | $0,3200 |
| 27 grudnia 2024 | $0,2700 |
| 27 września 2024 | $0,2700 |
| 28 czerwca 2024 | $0,2700 |
| 27 marca 2024 | $0,2700 |
| 28 grudnia 2023 | $0,2400 |
| 11 października 2023 | $0,2700 |
| 29 czerwca 2023 | $0,2394 |
| 30 marca 2023 | $0,2394 |
| 29 grudnia 2022 | $0,2216 |
| 29 września 2022 | $0,2216 |
| 23 czerwca 2022 | $0,2216 |
| 24 marca 2022 | $0,2216 |
| 29 grudnia 2021 | $0,1862 |
| 29 września 2021 | $0,1862 |
DHR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 12 37,5%
- Kup 15 46,9%
- Trzymaj 5 15,6%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
23 analityków · 2026-08-14Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $1.94 | $1.85 | 0.09% |
| 31 marca 2026 | $2.06 | $1.96 | 0.10% |
| 31 grudnia 2025 | $2.23 | $2.17 | 0.06% |
| 30 września 2025 | $1.89 | $1.74 | 0.15% |
| 30 czerwca 2025 | $1.80 | $1.66 | 0.14% |
| 31 marca 2025 | $1.88 | $1.66 | 0.22% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Cost of Revenue | $10.04B | $9.67B | $9.86B | $10.46B | $9.56B | $9.81B | $7.93B | $7.54B | $6.95B | $7.55B | $6.66B | $6.02B | |
| Gross Profit | $14.52B | $14.21B | $14.03B | $16.19B | $15.24B | $12.47B | $9.98B | $9.51B | $8.57B | $9.33B | $7.77B | $6.85B | |
| R&D Expense | $1.60B | $1.58B | $1.50B | $1.53B | $1.50B | $1.35B | $1.13B | $1.06B | $956M | $975M | $861M | $769M | |
| SG&A Expense | $8.23B | $7.76B | $7.33B | $7.12B | $6.82B | $6.90B | $5.59B | $5.39B | $5.04B | $5.62B | $4.75B | $4.04B | |
| Operating Income | $4.69B | $4.86B | $5.20B | $7.54B | $6.38B | $4.23B | $3.27B | $3.06B | $2.57B | $2.74B | $2.16B | $2.04B | |
| Interest Expense | · | · | $286M | $204M | $231M | $275M | $108M | $137M | $140M | $184M | $140M | $95M | |
| Interest Income | $30M | $117M | $303M | $41M | $11M | $71M | $139M | $9M | $8M | $200.0K | $5M | $13M | |
| Other Non-op | $-222M | $-56M | $-175M | $-227M | $450M | $494M | $12M | $35M | · | · | · | · | |
| Pretax Income | $4.23B | $4.65B | $5.04B | $7.15B | $6.51B | $4.50B | $3.31B | $2.96B | $2.54B | $2.61B | $2.04B | $2.09B | |
| Income Tax | $633M | $747M | $823M | $818M | $1.06B | $849M | $873M | $556M | $371M | $458M | $293M | $448M | |
| Net Income | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| EPS (Basic) | $5.07 | $5.33 | $6.44 | $9.80 | $8.77 | $4.97 | $4.11 | $3.78 | $3.58 | $3.69 | $4.81 | $3.70 | |
| EPS (Diluted) | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 | $4.89 | $4.05 | $3.74 | $3.53 | $3.65 | $4.74 | $3.63 | |
| Shares (Basic) | 712,700,000 | 731,000,000 | 736,500,000 | 725,100,000 | 714,600,000 | 706,200,000 | 715,000,000 | 700,600,000 | 695,800,000 | 691,200,000 | 698,100,000 | 702,200,000 | |
| Shares (Diluted) | 716,100,000 | 737,200,000 | 743,100,000 | 737,100,000 | 736,800,000 | 718,700,000 | 725,500,000 | 710,200,000 | 706,100,000 | 699,800,000 | 708,500,000 | 716,100,000 | |
| EBITDA | $4.69B | $4.86B | $7.37B | $10.91B | $9.63B | $6.01B | $4.46B | $4.71B | $4.26B | $3.88B | $4.52B | $4.37B |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $19.91B | $788M | $630M | $964M | $791M | $3.01B | |
| Receivables | $3.91B | $3.54B | $3.92B | $4.10B | $4.63B | $4.04B | $3.19B | $3.03B | $3.52B | $3.19B | $2.99B | $3.45B | |
| Inventory | $2.49B | $2.33B | $2.59B | $2.77B | $2.77B | $2.29B | $1.63B | $1.63B | $1.84B | $1.71B | $1.57B | $1.78B | |
| Prepaid Expense | $1.74B | $1.55B | $1.56B | $1.74B | $1.66B | $1.43B | $865M | $858M | $857M | $806M | $890M | $953M | |
| Current Assets | $12.76B | $9.50B | $13.94B | $15.88B | $11.65B | $13.80B | $25.60B | $7.09B | $6.85B | $6.67B | $7.84B | $9.43B | |
| PP&E (Net) | $5.53B | $4.99B | $4.55B | $3.71B | $3.53B | $3.26B | $2.30B | $2.25B | $2.22B | $2.35B | $2.30B | $1.67B | |
| PP&E (Gross) | $10.30B | $9.09B | $8.38B | $7.14B | $7.25B | $6.44B | $5.06B | $4.70B | $4.97B | $4.32B | $3.99B | $4.71B | |
| Accum. Depreciation | $4.77B | $4.10B | $3.83B | $3.43B | $3.46B | $3.18B | $2.76B | $2.45B | $2.52B | $1.96B | $1.69B | $2.54B | |
| Goodwill | $43.15B | $40.50B | $41.61B | $37.28B | $38.68B | $35.42B | $22.71B | $22.58B | $21.77B | $23.83B | $21.01B | $11.58B | |
| Intangibles | $17.82B | $18.57B | $20.75B | $19.82B | $22.84B | $21.28B | $9.75B | $10.28B | $11.67B | $11.82B | $10.55B | $7.06B | |
| Other Non-current Assets | $4.21B | $3.99B | $3.64B | $4.16B | $3.72B | $2.40B | $1.72B | $571M | $538M | $631M | $845M | $1.02B | |
| Total Assets | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Accrued Liabilities | $4.96B | $4.54B | $4.81B | $4.82B | $5.56B | $5.34B | $3.21B | $2.69B | $3.09B | $2.79B | $2.61B | $3.19B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $765M | |
| Current Liabilities | $6.81B | $6.80B | $8.27B | $8.39B | $8.14B | $7.40B | $4.93B | $4.84B | $4.79B | $6.87B | $6.17B | $5.40B | |
| Capital Leases | $1.08B | $968M | $954M | $772M | $889M | $785M | $639M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $5.70B | $5.69B | $6.02B | $6.50B | $7.70B | $7.79B | $5.35B | $4.70B | $5.16B | $5.67B | $5.75B | $4.58B | |
| Long-term Debt | $18.42B | $16.00B | $18.40B | $19.68B | $22.18B | $21.20B | $21.73B | $9.74B | $10.52B | $12.27B | $12.87B | $3.47B | |
| Total Debt | $18.42B | $15.50B | $16.71B | $19.09B | $22.17B | $21.19B | $21.52B | $9.69B | $10.33B | $9.67B | $12.03B | $4.17B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Retained Earnings | $46.89B | $44.19B | $41.07B | $39.20B | $32.83B | $27.16B | $24.17B | $25.16B | $22.81B | $20.70B | $21.01B | $20.32B | |
| Treasury Stock | $11.35B | $8.16B | $2.02B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-207M | $-3.22B | $-1.75B | $-2.87B | $-1.03B | $-368M | $-3.07B | $-2.79B | $-2.15B | $-3.02B | $-2.31B | $-1.43B | |
| Stockholders' Equity | $52.53B | $49.54B | $53.49B | $50.08B | $45.17B | $39.77B | $30.27B | $28.21B | $26.36B | $23.00B | $23.69B | $23.38B | |
| Liabilities + Equity | $83.46B | $77.54B | $84.49B | $84.35B | $83.18B | $76.16B | $62.08B | $47.83B | $46.65B | $45.30B | $48.22B | $36.99B | |
| Shares Outstanding | 706,900,000 | 719,100,000 | 739,200,000 | 728,300,000 | 715,000,000 | 711,000,000 | 695,500,000 | 701,500,000 | 696,600,000 | 692,200,000 | 686,800,000 | 704,300,000 |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2.17B | $2.13B | $2.06B | $1.77B | $1.19B | $1.18B | $1.12B | $1.13B | $881M | $718M | |
| Stock-based Comp | $298M | $288M | $306M | $295M | $184M | $187M | $159M | $138M | $127M | $130M | $104M | $85M | |
| Amort. of Intangibles | $1.70B | $1.63B | $1.49B | $1.43B | $1.39B | $1.14B | $625M | $616M | $579M | $583M | $397M | $269M | |
| Restructuring | · | · | · | · | · | · | · | $70M | $159M | $152M | $98M | $102M | |
| Other Non-cash | · | · | $-72M | $-1.25B | $-461M | $600M | $-405M | $-88M | $-392M | $-290M | $-746M | $100M | |
| Operating Cash Flow | $6.42B | $6.69B | $7.16B | $8.52B | $8.36B | $6.21B | $3.95B | $4.02B | $3.48B | $3.52B | $3.80B | $3.76B | |
| CapEx | $1.16B | $1.39B | $1.38B | $1.12B | $1.24B | $791M | $636M | $584M | $571M | $590M | $513M | $465M | |
| Investing Cash Flow | $-1.20B | $-1.98B | $-7.08B | $-2.23B | $-12.99B | $-21.24B | $-1.24B | $-2.95B | $-843M | $-5.24B | $-14.95B | $-3.44B | |
| Debt Issued | · | · | · | · | · | · | $12.11B | $0 | $1.78B | $3.24B | $5.68B | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $10.55B | $-508M | $1.11B | $760M | $5.65B | $-415M | |
| Stock Issued | · | · | · | $0 | $0 | $1.73B | $1.44B | $0 | $0 | $164M | $249M | $133M | |
| Stock Repurchased | $3.09B | $5.98B | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | $-3.09B | $-5.98B | · | $0 | $0 | $1.73B | $1.44B | $96M | $69M | $164M | $249M | $133M | |
| Dividends Paid | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M | |
| Financing Cash Flow | $-2.96B | $-8.38B | $-273M | $-2.57B | $1.29B | $1.01B | $16.36B | $-797M | $-3.10B | $2.04B | $9.05B | $-218M | |
| Net Change in Cash | $2.54B | $-3.79B | $-131M | $3.41B | $-3.45B | $-13.88B | $19.12B | $158M | $-333M | $173M | $-2.21B | $-110M | |
| Taxes Paid | $1.20B | $1.30B | $1.80B | $1.80B | $1.70B | · | · | · | · | · | · | · | |
| Free Cash Flow | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B | $5.42B | $3.32B | $3.37B | $2.86B | $2.93B | $3.17B | $3.16B | |
| Levered FCF | · | · | $5.54B | $7.18B | $6.87B | $5.19B | $3.24B | $3.24B | $2.72B | $2.78B | $3.04B | $3.07B |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% | 56.0% | 55.7% | 55.8% | 55.6% | 55.3% | 52.3% | 52.4% | |
| Operating Margin | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% | 19.0% | 18.2% | 17.1% | 16.5% | 16.3% | 16.9% | 17.2% | |
| Net Margin | 14.7% | 16.3% | 19.9% | 22.9% | 21.8% | 16.4% | 16.8% | 13.3% | 13.6% | 15.1% | 16.3% | 13.1% | |
| Pretax Margin | 17.2% | 19.5% | 21.1% | 26.4% | 25.8% | 20.2% | 18.4% | 16.6% | 16.0% | 15.5% | 16.2% | 17.5% | |
| EBITDA Margin | 19.1% | 20.4% | 30.8% | 34.7% | 32.7% | 27.0% | 24.9% | 23.7% | 23.2% | 23.0% | 22.0% | 21.9% | |
| ROA | 4.5% | 4.8% | 5.6% | 8.6% | 8.1% | 5.3% | 5.5% | 5.6% | 5.4% | 5.5% | 7.9% | 7.2% | |
| ROE | 7.1% | 7.6% | 9.2% | 15.1% | 15.2% | 10.4% | 10.3% | 9.7% | 10.1% | 10.9% | 14.3% | 11.4% | |
| ROIC | 5.6% | 6.3% | 6.2% | 10.9% | 9.3% | 5.6% | 4.7% | 7.2% | 6.9% | 6.9% | 7.6% | 9.3% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 | 1.9 | 5.2 | 1.5 | 1.4 | 1.0 | 1.3 | 1.7 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 4.7 | 0.9 | 0.9 | 0.6 | 0.8 | 1.2 | |
| Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.2 | |
| LT Debt / Equity | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.4 | 0.5 | 0.1 | |
| Interest Coverage | · | · | 18.2 | 41.2 | 31.4 | 15.4 | 30.1 | 21.6 | 18.6 | 14.9 | 21.3 | 28.0 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | |
| Inventory Turnover | 4.2 | 3.9 | 3.7 | 4.3 | 4.5 | 5.0 | 4.9 | 4.7 | 4.6 | 4.6 | 5.1 | 5.2 | |
| Receivables Turnover | 6.6 | 6.4 | 6.0 | 6.6 | 6.8 | 6.2 | 5.8 | 5.7 | 5.5 | 5.5 | 5.6 | 5.6 |
Stopy Wzrostu 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.9% | -0.06% | -10.3% | 7.4% | 11.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.7% | -1.3% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.5% | -17.1% | -34.0% | 12.2% | 76.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -19.4% | -15.0% | 9.3% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.65% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -7.3% | -18.2% | -33.9% | 12.1% | 76.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -20.6% | -15.4% | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.18% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 7.4% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B | $22.28B | $17.91B | $17.05B | $15.52B | $16.88B | $14.43B | $12.87B | |
| Net Income TTM | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B | $3.65B | $3.01B | $2.65B | $2.49B | $2.55B | $3.36B | $2.60B | |
| Market Cap | $161.82B | $165.07B | $171.01B | $171.37B | $208.55B | $140.02B | $94.63B | $64.13B | $57.32B | $47.77B | $56.55B | $53.52B | |
| Enterprise Value | · | · | · | · | · | · | $96.24B | $73.03B | $67.02B | $56.48B | $67.79B | $54.68B | |
| P/E | 45.3 | 43.4 | 36.3 | 24.4 | 33.9 | 40.3 | 33.6 | 24.4 | 23.3 | 18.9 | 17.4 | 20.9 | |
| P/S | 6.6 | 6.9 | 7.2 | 6.4 | 8.4 | 6.3 | 5.3 | 3.8 | 3.7 | 2.8 | 3.9 | 4.2 | |
| P/B | 3.1 | 3.3 | 3.2 | 3.4 | 4.6 | 3.5 | 3.1 | 2.3 | 2.2 | 2.1 | 2.4 | 2.3 | |
| P / Cash Flow | 25.2 | 24.7 | 23.9 | 20.1 | 25.0 | 22.6 | 23.9 | 15.9 | 16.5 | 13.6 | 14.9 | 14.2 | |
| P / FCF | 30.8 | 31.2 | 29.6 | 23.3 | 29.5 | 25.8 | 28.5 | 19.1 | 20.1 | 16.3 | 17.8 | 16.9 | |
| EV / EBITDA | · | · | · | · | · | · | 21.6 | 15.5 | 15.7 | 14.6 | 15.0 | 12.5 | |
| EV / FCF | · | · | · | · | · | · | 29.0 | 21.7 | 23.4 | 19.3 | 21.4 | 17.3 | |
| EV / Revenue | · | · | · | · | · | · | 5.4 | 4.3 | 4.3 | 3.3 | 4.7 | 4.2 | |
| Dividend Yield | 0.54% | 0.47% | 0.48% | 0.48% | 0.36% | 0.44% | 0.56% | 0.68% | 0.66% | 0.84% | 0.63% | 0.43% | |
| Earnings Yield | 2.2% | 2.3% | 2.8% | 4.1% | 2.9% | 2.5% | 3.0% | 4.1% | 4.3% | 5.3% | 5.8% | 4.8% | |
| Payout Ratio | 24.3% | 19.7% | 17.2% | 11.3% | 11.5% | 16.9% | 17.5% | 16.4% | 15.2% | 15.7% | 10.5% | 8.8% | |
| Annual Payout | $878M | $768M | $821M | $818M | $742M | $615M | $527M | $433M | $378M | $400M | $354M | $228M |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.26B | $5.95B | $6.84B | $6.05B | $5.94B | $5.74B | $6.54B | $5.80B | $5.74B | $5.80B | $6.41B | $5.62B | $5.91B | $5.95B | $3.54B | $6.46B | |
| Cost of Revenue | $2.65B | $2.36B | $2.87B | $2.53B | $2.41B | $2.23B | $2.65B | $2.40B | $2.31B | $2.31B | $2.63B | $2.35B | $2.59B | $2.29B | $1.36B | $3.08B | |
| Gross Profit | $3.61B | $3.59B | $3.97B | $3.52B | $3.52B | $3.51B | $3.89B | $3.40B | $3.43B | $3.49B | $3.78B | $3.27B | $3.32B | $3.66B | $2.18B | $3.89B | |
| R&D Expense | $412M | $387M | $438M | $378M | $403M | $379M | $442M | $383M | $391M | $368M | $407M | $362M | $361M | $373M | $236M | $420M | |
| SG&A Expense | $2.07B | $1.86B | $2.03B | $1.99B | $2.36B | $1.86B | $2.02B | $2.06B | $1.87B | $1.81B | $2.04B | $1.73B | $1.79B | $1.77B | $798M | $2.15B | |
| Operating Income | $1.13B | $1.34B | $1.50B | $1.15B | $760M | $1.27B | $1.43B | $958M | $1.17B | $1.31B | $1.34B | $1.19B | $1.16B | $1.52B | $1.14B | $1.72B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $65M | · | $73M | $67M | $66M | · | $42M | |
| Interest Income | $61M | $27M | $13M | $3M | $8M | $6M | $14M | $4M | $39M | $60M | $117M | $79M | $59M | $48M | $29M | $9M | |
| Other Non-op | $-3M | $-73M | $-87M | $-14M | $-42M | $-79M | $-63M | $102M | $-59M | $-36M | $-137M | $-47M | $-15M | $24M | $-69M | $-51M | |
| Pretax Income | $1.08B | $1.24B | $1.37B | $1.08B | $655M | $1.13B | $1.31B | $977M | $1.08B | $1.27B | $1.23B | $1.15B | $1.14B | $1.52B | $1.05B | $1.93B | |
| Income Tax | $208M | $206M | $190M | $168M | $100M | $175M | $229M | $159M | $176M | $183M | $111M | $207M | $222M | $283M | $-304M | $359M | |
| Net Income | $870M | $1.03B | $1.20B | $908M | $555M | $954M | $1.09B | $818M | $907M | $1.09B | $1.08B | $1.13B | $1.11B | $1.45B | $2.23B | $1.57B | |
| EPS (Basic) | $1.23 | $1.45 | $1.69 | $1.28 | $0.77 | $1.33 | $1.50 | $1.13 | $1.23 | $1.47 | $1.45 | $1.53 | $1.50 | $1.96 | $3.04 | $2.13 | |
| EPS (Diluted) | $1.23 | $1.45 | $1.69 | $1.27 | $0.77 | $1.32 | $1.50 | $1.12 | $1.22 | $1.45 | $1.44 | $1.51 | $1.49 | $1.94 | $2.99 | $2.10 | |
| Shares (Basic) | 705,300,000 | 707,900,000 | -1,430,800,000 | 710,700,000 | 716,500,000 | 716,300,000 | -1,470,200,000 | 723,000,000 | 737,600,000 | 740,600,000 | -1,469,600,000 | 739,400,000 | 737,300,000 | 729,400,000 | 1,300,000 | 728,500,000 | |
| Shares (Diluted) | 707,600,000 | 711,200,000 | -1,437,500,000 | 713,700,000 | 719,100,000 | 720,800,000 | -1,483,200,000 | 729,400,000 | 742,400,000 | 748,600,000 | -1,484,700,000 | 745,900,000 | 744,700,000 | 737,200,000 | 100,000 | 737,400,000 | |
| EBITDA | · | $1.34B | · | $1.15B | $760M | $1.27B | · | $958M | $1.17B | $1.31B | · | $1.44B | $1.43B | $1.79B | · | $2.02B |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3.96B | $3.82B | $3.91B | $3.75B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B | · | $4.20B | $4.20B | $4.31B | · | $4.41B | |
| Inventory | $3.26B | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.65B | · | $3.02B | $3.18B | $3.38B | · | $3.24B | |
| Prepaid Expense | $1.81B | $1.81B | $1.74B | $1.65B | $1.79B | $1.49B | $1.55B | $1.25B | $1.27B | $1.32B | · | $1.70B | $1.50B | $1.46B | · | $1.46B | |
| Current Assets | $13.38B | $13.94B | $12.76B | $9.61B | $11.00B | $9.53B | $9.50B | $10.06B | $9.61B | $14.37B | · | $21.20B | $17.46B | $16.53B | · | $14.25B | |
| PP&E (Net) | $5.83B | $5.47B | $5.53B | $5.38B | $5.31B | $5.11B | $4.99B | $4.84B | $4.64B | $4.56B | $4.55B | $4.30B | $4.18B | $4.07B | $3.71B | $3.72B | |
| PP&E (Gross) | · | · | $10.30B | · | · | · | $9.09B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.92B | $4.83B | $4.77B | $4.67B | $4.56B | $4.31B | $4.10B | $4.20B | $4.05B | $3.96B | · | $4.12B | $4.12B | $4.02B | · | $3.63B | |
| Goodwill | $47.41B | $42.77B | $43.15B | $42.95B | $42.99B | $41.66B | $40.50B | $42.17B | $40.80B | $40.85B | $41.61B | $39.16B | $39.58B | $39.86B | $37.28B | $38.25B | |
| Intangibles | $21.36B | $17.17B | $17.82B | $18.10B | $18.63B | $18.89B | $18.57B | $19.85B | $19.55B | $19.89B | · | $18.79B | $19.32B | $19.98B | · | $19.96B | |
| Other Non-current Assets | $4.39B | $4.21B | $4.21B | $3.87B | $3.69B | $3.94B | $3.99B | $3.69B | $3.95B | $3.73B | · | $4.29B | $4.37B | $4.61B | · | $4.85B | |
| Total Assets | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B | $87.73B | $84.90B | $85.04B | $84.35B | $81.03B | |
| Accrued Liabilities | $4.87B | $4.75B | $4.96B | $4.60B | $4.57B | $4.42B | $4.54B | $4.54B | $4.36B | $4.35B | · | $4.93B | $4.86B | $5.08B | · | $5.11B | |
| Current Liabilities | $8.11B | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B | · | $9.37B | $8.40B | $8.73B | · | $8.00B | |
| Capital Leases | · | · | $1.08B | · | · | · | $968M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $6.52B | $5.57B | $5.70B | $5.66B | $5.63B | $5.64B | $5.69B | $5.65B | $5.64B | $5.76B | · | $6.44B | $6.49B | $6.56B | · | $7.49B | |
| Long-term Debt | $26.56B | $18.48B | $18.42B | $16.86B | $17.36B | $16.48B | $16.00B | $17.52B | $17.01B | $18.16B | · | $22.06B | $19.88B | $19.83B | · | $19.25B | |
| Total Debt | · | $17.56B | · | $16.83B | $16.85B | $15.98B | · | $16.32B | $16.31B | $16.42B | · | $19.51B | $18.29B | $18.26B | · | $18.54B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Retained Earnings | $48.23B | $47.64B | $46.89B | $45.92B | $45.24B | $44.91B | $44.19B | $43.30B | $42.67B | $41.96B | · | $42.27B | $41.34B | $40.44B | · | $37.18B | |
| Treasury Stock | $12.32B | $11.41B | $11.35B | $11.34B | $9.30B | $9.31B | $8.16B | · | · | · | · | · | · | · | · | · | |
| AOCI | $-795M | $-593M | $-207M | $-590M | $-569M | $-1.61B | $-3.22B | $-1.31B | $-2.59B | $-2.74B | · | $-3.96B | $-3.58B | $-2.77B | $-2.87B | $-3.85B | |
| Stockholders' Equity | $52.58B | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | · | $52.41B | $51.72B | $51.48B | · | $46.98B | |
| Liabilities + Equity | $92.37B | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | · | $87.73B | $84.90B | $85.04B | · | $81.03B | |
| Shares Outstanding | 702,900,000 | 707,700,000 | 706,900,000 | 706,300,000 | 715,900,000 | 715,600,000 | 719,100,000 | 722,200,000 | 724,000,000 | 740,600,000 | · | 738,900,000 | 738,200,000 | 729,200,000 | · | 727,900,000 |
Przepływy pieniężne 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $93M | $58M | $63M | $83M | $91M | $61M | $57M | $84M | $87M | $60M | $61M | $57M | $87M | $70M | $25M | $89M | |
| Amort. of Intangibles | $463M | $434M | $428M | $433M | $426M | $410M | $408M | $414M | $402M | $407M | $380M | $343M | $360M | $372M | $314M | $361M | |
| Operating Cash Flow | $1.53B | $1.32B | $2.12B | $1.66B | $1.34B | $1.30B | $2.02B | $1.51B | $1.42B | $1.74B | $1.62B | $1.67B | $1.93B | $1.95B | $2.54B | $2.01B | |
| CapEx | $269M | $237M | $371M | $292M | $248M | $245M | $516M | $298M | $287M | $291M | $434M | $333M | $320M | $266M | $295M | $277M | |
| Investing Cash Flow | $-10.15B | $-249M | $-384M | $-312M | $-258M | $-242M | $-694M | $-606M | $-360M | $-321M | $-6.02B | $-329M | $-431M | $-304M | $-816M | $-515M | |
| Stock Repurchased | $894M | $0 | $0 | $2.01B | $0 | $1.08B | $809M | $640M | $4.53B | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-1.08B | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $283M | $226M | $226M | $229M | $229M | $194M | $195M | $196M | $200M | $177M | $200M | $199M | $218M | $204M | $203M | $204M | |
| Financing Cash Flow | $7.27B | $46M | $1.32B | $-2.78B | $-247M | $-1.25B | $-1.69B | $-845M | $-5.71B | $-133M | $-2.25B | $2.44B | $-208M | $-262M | $-906M | $-230M | |
| Net Change in Cash | $-1.35B | $1.09B | $3.09B | $-1.43B | $964M | $-85M | $-549M | $253M | $-4.66B | $1.17B | $-6.41B | $3.70B | $1.20B | $1.38B | $845M | $1.17B | |
| Taxes Paid | $350M | $191M | $392M | $277M | $330M | $201M | $367M | $315M | $396M | $222M | $630M | $476M | $466M | $228M | $706M | $469M | |
| Free Cash Flow | · | $1.08B | · | · | · | $1.05B | · | · | · | $1.45B | · | · | · | $1.67B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.39B | · | · | · | $1.62B | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 60.3% | · | 58.2% | 59.4% | 61.2% | · | 58.7% | 59.7% | 60.2% | · | 58.2% | 56.5% | 61.0% | · | 59.8% | |
| Operating Margin | · | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| Net Margin | 13.9% | 17.3% | · | 15.0% | 9.3% | 16.6% | · | 14.1% | 15.8% | 18.8% | · | 16.4% | 15.4% | 20.2% | · | 20.5% | |
| Pretax Margin | 17.2% | 20.8% | · | 17.8% | 11.0% | 19.7% | · | 16.9% | 18.9% | 21.9% | · | 20.3% | 19.4% | 25.1% | · | 25.2% | |
| EBITDA Margin | 18.0% | 22.6% | · | 19.1% | 12.8% | 22.2% | · | 16.5% | 20.3% | 22.6% | · | 20.9% | 20.0% | 25.0% | · | 26.3% | |
| ROA | 1.0% | 1.3% | · | 1.1% | 0.69% | 1.2% | · | 0.97% | 1.1% | 1.3% | · | 1.3% | 1.3% | 1.7% | · | 1.9% | |
| ROE | 1.7% | 2.0% | · | 1.8% | 1.1% | 1.8% | · | 1.6% | 1.8% | 2.1% | · | 2.3% | 2.2% | 3.0% | · | 3.5% | |
| ROIC | 1.2% | 1.6% | · | 1.4% | 0.93% | 1.6% | · | 1.2% | 1.5% | 1.6% | · | 1.6% | 1.6% | 2.1% | · | 2.5% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.5 | 1.6 | 1.4 | · | 1.4 | 1.4 | 1.8 | · | 2.3 | 2.1 | 1.9 | · | 1.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.5 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 20.2 | · | 19.7 | 21.3 | 26.4 | · | 48.0 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | 0.9 | · | 1.2 | |
| Receivables Turnover | · | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.8 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24.20B | $23.68B | · | $23.53B | $23.22B | $23.08B | · | $23.74B | $23.57B | $23.74B | · | $24.62B | $25.45B | $26.07B | · | $26.74B | |
| Net Income TTM | $3.36B | $3.45B | · | $3.23B | $3.23B | $3.77B | · | $3.94B | $4.23B | $4.77B | · | $5.26B | $5.81B | $6.43B | · | $6.13B | |
| Market Cap | $137.90B | $128.46B | · | $130.55B | $142.32B | $147.31B | · | $198.92B | $180.89B | $184.94B | · | $162.52B | $157.06B | $162.93B | · | $166.67B | |
| P/E | 41.6 | 37.7 | · | 41.3 | 44.9 | 40.3 | · | 52.6 | 44.4 | 42.3 | · | 27.7 | 25.0 | 24.1 | · | 27.9 | |
| P/S | 5.7 | 5.4 | · | 5.5 | 6.1 | 6.4 | · | 8.4 | 7.7 | 7.8 | · | 6.6 | 6.2 | 6.3 | · | 6.2 | |
| P/B | 2.6 | 2.4 | · | 2.6 | 2.7 | 2.9 | · | 3.9 | 3.6 | 3.5 | · | 3.1 | 3.0 | 3.2 | · | 3.5 | |
| P / Cash Flow | · | 97.2 | · | · | · | 113.4 | · | · | · | 106.3 | · | · | · | 83.7 | · | · | |
| P / FCF | · | 118.4 | · | · | · | 139.8 | · | · | · | 127.7 | · | · | · | 97.4 | · | · | |
| Earnings Yield | 2.4% | 2.6% | · | 2.4% | 2.2% | 2.5% | · | 1.9% | 2.2% | 2.4% | · | 3.6% | 4.0% | 4.2% | · | 3.6% | |
| Payout Ratio | · | 22.0% | · | · | · | 20.3% | · | · | · | 16.3% | · | · | · | 14.1% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $24.57B | $23.88B | $23.89B | $26.64B | $24.80B |
| Marża Brutto % | 59.1% | 59.5% | 58.7% | 60.2% | 61.0% |
| Marża Operacyjna % | 19.1% | 20.4% | 21.8% | 27.6% | 25.4% |
| Zysk netto | $3.61B | $3.90B | $4.76B | $7.21B | $6.43B |
| Rozwodniony EPS | $5.05 | $5.29 | $6.38 | $9.66 | $8.61 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| Wskaźnik bieżący | 1.9 | 1.4 | 1.7 | 1.9 | 1.4 |
| Wskaźnik Szybkości | 0.6 | 0.5 | 0.5 | 0.6 | 0.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $5.26B | $5.30B | $5.78B | $7.37B | $7.06B |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Danaher Corp. Reveals Rise In Q2 Income
- Ex-Div Reminder for Danaher (DHR)
- Solid Q1 i Prognozy Podkreślają, Dlaczego Danaher Corporation (DHR) Jest Jednym z Wyborów Akcji Dużej Kapitalizacji Steve'a Cohena
- Danaher Corporation (DHR) Raportuje Przekroczenie Prognozowanych Wyników EPS Skorygowanych za I Kwartał
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 2 341 emitentów · $71.5B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 156 (-42 vs poprzedni kw.) | 180 (-75 vs poprzedni kw.) | 675 (-90 vs poprzedni kw.) | 980 (+58 vs poprzedni kw.) | +77.9M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $7 881 505 437 | 41 377 076 | 11,02% | Akcje |
| STATE STREET CORP | $5 431 565 288 | 28 456 019 | 7,60% | Akcje |
| FMR LLC | $3 977 715 242 | 20 882 587 | 5,56% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $3 015 682 979 | 15 832 019 | 4,22% | Akcje |
| Capital International Investors | $2 953 960 497 | 15 504 420 | 4,13% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 705 808 973 | 14 205 213 | 3,78% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $2 313 841 539 | 12 214 999 | 3,24% | Akcje |
| Capital Research Global Investors | $2 060 650 455 | 10 818 030 | 2,88% | Akcje |
| NORGES BANK | $1 816 780 335 | 9 537 906 | 2,54% | Akcje |
| EAGLE CAPITAL MANAGEMENT LLC | $1 783 176 557 | 9 361 490 | 2,49% | Akcje |
| GENERATION INVESTMENT MANAGEMENT LLP | $1 287 948 806 | 6 761 596 | 1,80% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $983 459 478 | 5 163 059 | 1,38% | Akcje |
| Fisher Asset Management, LLC | $854 260 080 | 4 484 774 | 1,19% | Akcje |
| FLOSSBACH VON STORCH SE | $747 259 707 | 3 923 035 | 1,05% | Akcje |
| PARNASSUS INVESTMENTS, LLC | $699 862 950 | 3 674 207 | 0,98% | Akcje |
| Holocene Advisors, LP | $684 356 163 | 3 592 798 | 0,96% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $674 795 972 | 3 542 608 | 0,94% | Akcje |
| D1 Capital Partners L.P. | $434 682 789 | 2 282 039 | 0,61% | Akcje |
| FIRST MANHATTAN CO. LLC. | $429 106 102 | 2 248 424 | 0,60% | Akcje |
| BlackRock, Inc. | $424 712 304 | 2 229 695 | 0,59% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $423 080 600 | 2 221 129 | 0,59% | Akcje |
| GOLDMAN SACHS GROUP INC | $412 955 174 | 2 167 971 | 0,58% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $410 455 346 | 2 154 842 | 0,57% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $407 739 012 | 2 140 587 | 0,57% | Akcje |
| Castle Hook Partners LP | $404 836 478 | 2 125 349 | 0,57% | Akcje |
| AMERIPRISE FINANCIAL INC | $392 617 529 | 2 061 025 | 0,55% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $389 240 356 | 2 043 471 | 0,54% | Akcje |
| 1832 Asset Management L.P. | $364 584 815 | 1 914 032 | 0,51% | Akcje |
| PRIMECAP MANAGEMENT CO/CA/ | $359 830 054 | 1 889 070 | 0,50% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $355 388 763 | 1 865 754 | 0,50% | Akcje |
| Swiss National Bank | $342 198 844 | 1 796 508 | 0,48% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $341 443 781 | 1 792 544 | 0,48% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $339 224 793 | 1 780 339 | 0,47% | Akcje |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $318 260 440 | 1 670 835 | 0,45% | Akcje |
| BANK OF AMERICA CORP /DE/ | $301 393 888 | 1 582 286 | 0,42% | Akcje |
| Legal & General Group Plc | $295 737 157 | 1 552 589 | 0,41% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $295 010 472 | 1 548 774 | 0,41% | Akcje |
| FIL Ltd | $290 578 764 | 1 525 508 | 0,41% | Akcje |
| National Pension Service | $285 900 766 | 1 500 949 | 0,40% | Akcje |
| VAN ECK ASSOCIATES CORP | $281 058 192 | 1 475 526 | 0,39% | Akcje |
| Southpoint Capital Advisors LP | $266 672 000 | 1 400 000 | 0,37% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $263 806 038 | 1 384 954 | 0,37% | Akcje |
| Anomaly Capital Management, LP | $260 066 154 | 1 365 320 | 0,36% | Akcje |
| Vanguard Global Advisers, LLC | $258 865 177 | 1 359 015 | 0,36% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $257 409 127 | 1 351 371 | 0,36% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $246 675 000 | 1 295 020 | 0,35% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $241 732 034 | 1 269 068 | 0,34% | Akcje |
| Sustainable Growth Advisers, LP | $239 075 067 | 1 255 119 | 0,33% | Akcje |
| AVIVA PLC | $237 495 036 | 1 246 824 | 0,33% | Akcje |
| California Public Employees Retirement System | $235 582 426 | 1 236 783 | 0,33% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $232 825 990 | 1 222 312 | 0,33% | Akcje |
| UBS Group AG | $222 739 883 | 1 169 361 | 0,31% | Akcje |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $218 286 080 | 1 145 979 | 0,31% | Akcje |
| Nuveen, LLC | $214 912 083 | 1 128 266 | 0,30% | Akcje |
| PRUDENTIAL FINANCIAL INC | $213 476 650 | 1 120 730 | 0,30% | Akcje |
| KING LUTHER CAPITAL MANAGEMENT CORP | $206 309 650 | 1 083 104 | 0,29% | Akcje |
| MONTRUSCO BOLTON INVESTMENTS INC. | $202 781 580 | 1 064 582 | 0,28% | Akcje |
| MACKENZIE FINANCIAL CORP | $198 886 263 | 1 044 132 | 0,28% | Akcje |
| ROYAL LONDON ASSET MANAGEMENT LTD | $191 867 454 | 1 007 284 | 0,27% | Akcje |
| Mirova US LLC | $190 479 238 | 999 996 | 0,27% | Akcje |
| RHUMBLINE ADVISERS | $189 703 347 | 995 923 | 0,27% | Akcje |
| BLAIR WILLIAM & CO/IL | $184 974 108 | 971 095 | 0,26% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $184 610 866 | 973 686 | 0,26% | Akcje |
| CITADEL ADVISORS LLC | $179 754 833 | 943 694 | 0,25% | Akcje |
| BARCLAYS PLC | $173 566 710 | 911 207 | 0,24% | Akcje |
| Qube Research & Technologies Ltd | $160 863 027 | 844 514 | 0,22% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $158 843 698 | 809 642 | 0,22% | Akcje |
| JANE STREET GROUP, LLC | $157 469 816 | 826 700 | 0,22% | Opcja kupna |
| Unisphere Establishment | $154 098 320 | 809 000 | 0,22% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $144 885 945 | 760 636 | 0,20% | Akcje |
| Balyasny Asset Management L.P. | $144 613 749 | 759 207 | 0,20% | Akcje |
| CI INVESTMENTS INC. | $143 569 157 | 753 723 | 0,20% | Akcje |
| Focus Partners Wealth | $138 144 377 | 725 093 | 0,19% | Akcje |
| Corient Private Wealth LP | $134 474 841 | 705 975 | 0,19% | Akcje |
| Squarepoint Ops LLC | $133 894 678 | 702 933 | 0,19% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $131 380 532 | 689 734 | 0,18% | Akcje |
| DAVENPORT & Co LLC | $129 567 583 | 678 343 | 0,18% | Akcje |
| JUPITER ASSET MANAGEMENT LTD | $128 724 672 | 672 386 | 0,18% | Akcje |
| JOHNSON INVESTMENT COUNSEL INC | $124 418 228 | 653 183 | 0,17% | Akcje |
| Alecta Tjanstepension Omsesidigt | $123 111 539 | 646 900 | 0,17% | Akcje |
| Dorsey Asset Management, LLC | $119 280 671 | 626 211 | 0,17% | Akcje |
| Pictet Asset Management Holding SA | $119 219 547 | 625 690 | 0,17% | Akcje |
| Aberdeen Group plc | $118 872 663 | 624 069 | 0,17% | Akcje |
| FRANKLIN RESOURCES INC | $116 674 905 | 612 531 | 0,16% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $114 452 230 | 603 651 | 0,16% | Akcje |
| Welch & Forbes LLC | $113 968 746 | 598 324 | 0,16% | Akcje |
| JENNISON ASSOCIATES LLC | $113 865 135 | 597 780 | 0,16% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $112 932 032 | 589 589 | 0,16% | Akcje |
| BRADLEY FOSTER & SARGENT INC/CT | $111 570 652 | 585 734 | 0,16% | Akcje |
| JARISLOWSKY, FRASER Ltd | $109 881 639 | 554 230 | 0,15% | Akcje |
| First Pacific Advisors, LP | $107 579 485 | 564 781 | 0,15% | Akcje |
| Woodline Partners LP | $107 477 769 | 564 247 | 0,15% | Akcje |
| EMINENCE CAPITAL, LP | $106 409 966 | 561 234 | 0,15% | Akcje |
| Canoe Financial LP | $106 328 603 | 558 214 | 0,15% | Akcje |
| Mariner, LLC | $105 627 587 | 554 431 | 0,15% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $105 203 437 | 552 307 | 0,15% | Akcje |
| Third Point LLC | $102 859 200 | 540 000 | 0,14% | Akcje |
| Meridiem Capital Partners LP | $102 371 000 | 537 437 | 0,14% | Akcje |
| Spear Holdings RSC Ltd | $101 874 609 | 534 831 | 0,14% | Akcje |
| PBCay One RSC Ltd | $101 868 133 | 534 797 | 0,14% | Akcje |
Insiderzy spółki 51 insiderów · 24 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Rainer Blair | President & CEO | 1 marca 2026 A | 37 988 | 0 | 0 | $0 |
| Thomas Patrick Joyce JR | President and CEO | 24 lipca 2020 M | 203 513 | 0 | 0 | $0 |
| Lawrence H Culp JR | President and CEO | 18 lipca 2014 M | 512 199 | 0 | 0 | $0 |
| Georgeann Couchara | SVP, Human Resources | 15 maja 2026 F | 8 291 | 0 | 2 | $-1 088 686 |
| Matthew Mcgrew | Executive Vice President | 1 marca 2026 A | 26 825 | 0 | 1 | $-3 470 835 |
| Bradley R Gray | SVP Strategic Development | 1 marca 2026 A | 14 463 | 0 | 0 | $0 |
| Brian W Ellis | Senior Vice President | 4 lutego 2026 A | 14 994 | 0 | 2 | $-4 773 810 |
| Daniel Raskas | SVP - Corporate Development | 1 lutego 2025 A | 10 524 | 0 | 0 | $0 |
| William King | SVP, Strategic Development | 15 maja 2024 M | 48 190 | 0 | 0 | $0 |
| Joakim Weidemanis | Executive Vice President | 15 maja 2024 F | 87 333 | 0 | 0 | $0 |
| Jennifer Honeycutt | Executive Vice President | 15 maja 2023 F | 26 165 | 0 | 0 | $0 |
| Angela S Lalor | SVP, Human Resources | 24 lutego 2022 A | 47 962 | 0 | 0 | $0 |
| Robert S Lutz | SVP-Chief Accounting Officer | 21 maja 2021 S | 16 155 | 0 | 0 | $0 |
| William K Daniel | EVP | 20 lutego 2020 A | 109 886 | 0 | 0 | $0 |
| James A Lico | Executive Vice President | 10 maja 2016 A | 113 198 | 0 | 0 | $0 |
| Mark A Beck | Executive Vice President | 28 lipca 2015 S | 0 | 0 | 0 | $0 |
| Jonathan P Graham | Senior VP & GC | 19 maja 2015 M | 34 606 | 0 | 0 | $0 |
| James H Ditkoff | Senior VP-Finance & Tax | 21 lutego 2015 F | 174 406 | 0 | 0 | $0 |
| Philip Knisely | Executive Vice President | 29 stycznia 2010 A | 5 010 | 0 | 0 | $0 |
| Steve Simms | Executive Vice President | 26 października 2007 A | 4 400 | 0 | 0 | $0 |
| Patrick W Allender | Executive VP | 1 lutego 2007 M | 75 813 | 0 | 0 | $0 |
| Daniel A Pryor | VP-Strategic Development | 4 maja 2005 A | 0 | 0 | 0 | $0 |
| Donald E Doles | VP-Danaher Business System | 31 sierpnia 2004 A | — | 0 | 0 | $0 |
| Chris Mcmahon | VP -- Controller | 1 stycznia 2004 A | 0 | 0 | 0 | $0 |
| Charles W Lamanna | Dyrektor | 15 maja 2026 A | 1 359 | 0 | 0 | $0 |
| John T Schwieters | Dyrektor | 15 lipca 2025 M | 19 815 | 0 | 0 | $0 |
| Jessica L Mega | Dyrektor | 15 maja 2025 A | 3 302 | 0 | 0 | $0 |
| Pardis C Sabeti | Dyrektor | 25 października 2024 A | 5 283 | 0 | 0 | $0 |
| Walter G Lohr | Dyrektor | 15 lutego 2024 M | 14 129 | 0 | 0 | $0 |
| Donald J Ehrlich | Dyrektor | 10 lutego 2020 M | 123 203 | 0 | 0 | $0 |
| Robert J Hugin | Dyrektor | 15 maja 2017 A | 3 576 | 0 | 0 | $0 |
| Mortimer M Caplin | Dyrektor | 26 kwietnia 2013 A | 83 213 | 0 | 0 | $0 |
| Emmet A Stephenson JR | Dyrektor | 30 listopada 2007 M | 368 240 | 0 | 0 | $0 |
| DANAHER CORP /DE/ | Posiadacz 10% | 30 września 2023 J | 0 | 0 | 0 | $0 |
| Matthew E Gugino | — | 4 sierpnia 2026 A | 11 401 | 0 | 0 | $0 |
| Gregory M Milosevich | — | 4 sierpnia 2026 A | 24 467 | 0 | 1 | $-274 573 |
| Montgomery Julie A Sawyer | — | 4 sierpnia 2026 A | 22 221 | 0 | 0 | $0 |
| Christopher Paul Riley | — | 4 sierpnia 2026 A | 61 472 | 0 | 0 | $0 |
| Christopher Bouda | — | 4 sierpnia 2026 A | 9 107 | 0 | 0 | $0 |
| Jose-Carlos Gutierrez-Ramos | — | 4 sierpnia 2026 A | 32 495 | 0 | 0 | $0 |
| Jonathan Leiken | — | 4 sierpnia 2026 A | 12 546 | 0 | 0 | $0 |
| Mitchell P. Rales | — | 4 sierpnia 2026 A | 553 228 | 0 | 9 | $-234 561 260 |
| Steven M Rales | — | 4 sierpnia 2026 A | 3 605 808 | 0 | 0 | $0 |
| Shane A Sanders | — | 31 lipca 2026 A | 5 914 | 0 | 0 | $0 |
| Raymond C Stevens | — | 31 lipca 2026 A | 13 728 | 0 | 0 | $0 |
| Teri List-Stoll | — | 31 lipca 2026 A | 21 470 | 0 | 2 | $-1 333 322 |
| Feroz Dewan | — | 31 lipca 2026 A | 4 686 | 0 | 0 | $0 |
| Elias A. Zerhouni | — | 31 lipca 2026 A | 45 303 | 0 | 0 | $0 |
| Linda P Hefner | — | 31 lipca 2026 A | 26 829 | 0 | 0 | $0 |
| Alan G Spoon | — | 31 lipca 2026 A | 124 774 | 0 | 1 | $-237 202 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Mitchell P. Rales ×9 zgłoszenia | 2 listopada 2021 | — | Pierwotne zgłoszenie | — | SEC |
| Steven M. Rales ×6 zgłoszenia | 14 czerwca 2021 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 22 października 2014 | — | Pierwotne zgłoszenie | — | SEC |
| Danaher Corporation., Aegean Acquisition Corp. ×2 zgłoszenia | 9 grudnia 2010 | — | Pierwotne zgłoszenie | — | SEC |
| Danaher Corporation, DH Holdings Corp., DH Technologies Development Pte. Ltd. ×3 zgłoszenia | 5 lutego 2010 | — | Pierwotne zgłoszenie | — | SEC |
| Equity Group Holdings LLC, Equity Group Holdings II LLC, Steven M. Rales, Mitchell P. Rales ×6 zgłoszenia | 30 marca 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 23 kwietnia 2003 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 8 czerwca 2001 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 25 maja 2001 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 193 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PRCS · Parnassus Funds II | 5,06% | 42 782 NS | 30 czerwca 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 3,42% | 7 675 NS | 31 maja 2026 | N-PORT |
| MBCC · Northern Lights Fund Trust IV | 3,31% | 33 421 NS | 31 maja 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,66% | 7 557 NS | 31 maja 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 2,45% | 30 573 NS | 30 kwietnia 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 2,43% | 3 739 NS | 30 kwietnia 2026 | N-PORT |
| YALL · Tidal Trust I | 2,29% | 12 162 NS | 31 maja 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2,22% | 8 213 NS | 31 maja 2026 | N-PORT |
| IYH · iShares Trust | 2,06% | 378 380 SH | 8 sierpnia 2026 | Dziennie |
| JXX · Janus Detroit Street Trust | 1,92% | 3 881 NS | 30 kwietnia 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,90% | 1 184 NS | 30 kwietnia 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,84% | 293 052 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,79% | 1 914 802 SH | 8 sierpnia 2026 | Dziennie |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,69% | 64 507 SH | 8 sierpnia 2026 | Dziennie |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,68% | 5 006 NS | 30 kwietnia 2026 | N-PORT |
| RXL · ProShares Trust | 1,66% | 6 560 NS | 31 maja 2026 | N-PORT |
| ANEW · ProShares Trust | 1,66% | 701 NS | 31 maja 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,62% | 12 545 NS | 30 kwietnia 2026 | N-PORT |
| IXJ · iShares Trust | 1,59% | 331 014 SH | 8 sierpnia 2026 | Dziennie |
| FMCX · Northern Lights Fund Trust IV | 1,56% | 10 073 NS | 31 maja 2026 | N-PORT |
| SAWG · ETF Series Solutions | 1,38% | 194 NS | 30 kwietnia 2026 | N-PORT |
| NULV · Nushares ETF Trust | 1,26% | 146 061 NS | 30 kwietnia 2026 | N-PORT |
| GRW · TCW ETF Trust | 1,21% | 4 855 NS | 30 kwietnia 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1,19% | 3 038 NS | 30 kwietnia 2026 | N-PORT |
| GNOM · Global X Funds | 1,17% | 3 573 NS | 31 maja 2026 | N-PORT |
| NULC · Nushares ETF Trust | 1,11% | 3 541 NS | 30 kwietnia 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,07% | 6 377 NS | 30 kwietnia 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,05% | 142 630 SH | 8 sierpnia 2026 | Dziennie |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 0,92% | 1 138 NS | 30 kwietnia 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,89% | 8 584 NS | 30 kwietnia 2026 | N-PORT |
| ROPE · EA Series Trust | 0,88% | 408 NS | 29 maja 2026 | N-PORT |
| SNPV · DBX ETF Trust | 0,78% | 9 793 NS | 29 maja 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,75% | 45 913 NS | 30 kwietnia 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0,75% | 12 657 NS | 31 maja 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,75% | 1 089 NS | 30 kwietnia 2026 | N-PORT |
| XT · iShares Trust | 0,71% | 138 526 SH | 8 sierpnia 2026 | Dziennie |
| CGCV · Capital Group Conservative Equity E… | 0,63% | 60 285 NS | 31 maja 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,58% | 165 000 | 8 sierpnia 2026 | Dziennie |
| MFSG · MFS Active Exchange Traded Funds Tr… | 0,57% | 10 794 NS | 31 maja 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,57% | 400 375 SH | 8 sierpnia 2026 | Dziennie |
| CAPE · DoubleLine ETF Trust | 0,56% | 7 655 NS | 31 marca 2026 | N-PORT |
| CRTC · DBX ETF Trust | 0,55% | 3 919 NS | 31 maja 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,52% | 3 558 711 SH | 8 sierpnia 2026 | Dziennie |
| PFM · Invesco Exchange-Traded Fund Trust | 0,51% | 20 146 SH | 8 sierpnia 2026 | Dziennie |
| USXF · iShares Trust | 0,50% | 37 107 SH | 8 sierpnia 2026 | Dziennie |
| JSTC · Tidal Trust I | 0,47% | 8 617 NS | 31 maja 2026 | N-PORT |
| IWX · iShares Trust | 0,47% | 93 476 SH | 8 sierpnia 2026 | Dziennie |
| VTV · VANGUARD INDEX FUNDS | 0,45% | 6 058 224 SH | 8 sierpnia 2026 | Dziennie |
| EVUS · iShares Trust | 0,43% | 8 088 SH | 8 sierpnia 2026 | Dziennie |
| IVE · iShares Trust | 0,42% | 1 043 497 SH | 8 sierpnia 2026 | Dziennie |